Brokerages Set Outlook Therapeutics, Inc. (NASDAQ:OTLK) Price Target at $10.20
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five analysts that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year price objective […]
Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five analysts that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 year price objective […]
